Navigation Links
Warner Chilcott to Present at the Goldman Sachs Leveraged Finance Healthcare Conference
Date:3/4/2011

DUBLIN, Ireland, March 4, 2011 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the Goldman Sachs Leveraged Finance Healthcare Conference on Tuesday, March 8th at 12:35 p.m. ET.  

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets.  The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products.  WCRX-G


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Warner Chilcott Seeks to Refinance its Existing Credit Agreement
2. Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010
3. Warner Chilcott to Present at the Citi 2011 Global Health Care Conference
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2010 Financial Results
5. Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Warner Chilcott to Present at the Bank of America Merrill Lynch Credit Conference
7. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
8. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
9. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
10. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
11. Warner Chilcott Announces FDA Approval of Next Generation Actonel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... expects revenues for the fourth quarter of 2013 will ... to approximately $208 million. "Our full-year revenue ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Aeschliman family of Midland, Michigan have a new lease ... Chris, and Mike ALL underwent Roux-en-Y bariatric ... County to offer this life-changing surgery. The surgeries were ... amazing. The family has lost 445 pounds, and counting. ...
... March 18, 2011 Eli Lilly and ... subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter ... New Drug Application (NDA) for Amyvid™ (florbetapir F 18 injection), ... the detection of beta-amyloid plaque in the brains of living ...
Cached Medicine Technology:Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Counting—Tells their Life-Saving Story to Media on March 18, 2011 2Lilly and Avid Receive Complete Response Letter from FDA for Amyvid™ (florbetapir F 18 injection) 2
(Date:4/24/2014)... 24, 2014 Scientific research at UT Southwestern Medical ... heal itself completely, whereas the adult heart lacks this ... revealed why the heart loses its incredible regenerative capability ... oxygen. , Yes, oxygen. It is well-known that ... oxygen-rich blood throughout the body. But at the same ...
(Date:4/24/2014)... - Contact lenses coated with an antimicrobial peptide could help ... study in Optometry and Vision Science , ... The journal is published by Lippincott Williams & ... , Studies in animals and now humans support the biocompatibility ... according to the new research by Debarun Dutta, B.Optom, of ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... professor in the new Institute for Biomedical Sciences ... $2.83 million federal grant to develop novel therapeutics ... grant from the Eunice Kennedy Shriver National Institute ... National Institutes of Health will support Plemper,s drug ... at least one distinct alternative compound. , Infections ...
(Date:4/24/2014)... relevance of palliation in advanced cancer are often ... (RCTs). This is the result of an analysis ... in Health Care (IQWiG), which has now been ... experts, IQWiG analysed studies on four solid tumours ... pancreatic cancer. For this purpose, the research team ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... 15 Law Offices of Howard G. Smith,announces ... Inc. ("Inverness Medical" or the "Company") (Amex: ... (the "Plan"),imprudently invested in Inverness Medical stock and ... the Plan,s participants,in violation of the Employee Retirement ...
... New president and chief financial officer also appointed, ... named,chairman and chief executive officer of LifeCare Holdings, Inc., ... Plano, Texas.,Chief Financial Officer Phillip B. Douglas has been ... formerly chief accounting officer,will now serve as CFO., ...
... children with asthma may be particularly vulnerable to ... standards. The study, available online today, analyzes the ... symptoms and lung function in children. The study ... (NIH) and the Environmental Protection Agency (EPA). , ...
... scramble to file on,time, hundreds of people ... and,Congressional delegation to make wiser investments in ... Illinois annually from federal tax,sources supporting abstinence-only-until-marriage ... from mentioning contraceptives,or condoms except to discuss ...
... First oral drug could benefit many with the autoimmune disease, ... first pill designed to reduce the number of attacks in ... tests, Italian researchers report. , The pill was effective in ... took the pill for three years, according to research that ...
... Primary Less Than One Week Away, AARP Members,Gather ... They Debate,In Philadelphia., PHILADELPHIA, April 15 ... primary vote, the nation will be,watching Sen. Barack ... for,the Democratic Party,s presidential nomination during a debate ...
Cached Medicine News:Health News:LifeCare Holdings, Inc. Names McAlister Chairman and CEO 2Health News:Air pollution affects respiratory health in children with asthma 2Health News:Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely 2Health News:Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely 3Health News:Pill Reduces Relapses in MS Patients 2Health News:AARP to Host Discussion and Debate Watch Event 2Health News:AARP to Host Discussion and Debate Watch Event 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: